Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Herpen, C.M.L. van
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(28)
+
-
Availability
Open access
(13)
+
-
Metadata Only
(16)
+
-
Creation Date
2018
(5)
+
-
2022
(5)
+
-
2019
(3)
+
-
2012
(2)
+
-
2013
(2)
+
-
2015
(2)
+
-
2016
(2)
+
-
2017
(2)
+
-
2020
(2)
+
-
2023
(2)
+
-
Show more
Faculty
Leiden University Medical Center (LUMC)
(27)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(27)
+
-
Scholarly Publications
(2)
+
-
Topic
Chemoradiotherapy
(2)
+
-
Head and neck cancer
(2)
+
-
Induction chemotherapy
(2)
+
-
Renal cell carcinoma
(2)
+
-
androgen receptors
(2)
+
-
pazopanib
(2)
+
-
pharmacokinetics
(2)
+
-
salivary duct carcinoma
(2)
+
-
salivary gland neoplasms
(2)
+
-
Show more
Author
Herpen, C.M.L. van
(29)
+
-
Graaf, W.T.A. van der
(17)
+
-
Gelderblom, H.
(14)
+
-
Hoeben, A.
(7)
+
-
Erp, N.P. van
(6)
+
-
Boer, J.P. de
(5)
+
-
Driessen, C.M.L.
(5)
+
-
Beerepoot, L.V.
(4)
+
-
Groot, J.W.B. de
(4)
+
-
Henegouwen, J.M.V.
(4)
+
-
Hoes, L.R.
(4)
+
-
Jonker, M.A.
(4)
+
-
Kaanders, J.H.A.M.
(4)
+
-
Mulder, S.F.
(4)
+
-
Oosting, S.F.
(4)
+
-
Roepman, P.
(4)
+
-
Slingerland, M.
(4)
+
-
Tesselaar, M.E.T.
(4)
+
-
Verbist, B.M.
(4)
+
-
Verheul, H.M.W.
(4)
+
-
Voest, E.E.
(4)
+
-
Wijngaart, H. van der
(4)
+
-
Boon, E.
(3)
+
-
Burger, D.M.
(3)
+
-
Cuppen, E.
(3)
+
-
Desar, I.M.E.
(3)
+
-
Es, R.J.J. van
(3)
+
-
Flucke, U.E.
(3)
+
-
Huitema, A.D.R.
(3)
+
-
Jansen, A.M.L.
(3)
+
-
Jong, R.J.B. de
(3)
+
-
Kapiteijn, E.
(3)
+
-
Labots, M.
(3)
+
-
Noort, V. van der
(3)
+
-
Rasch, C.R.N.
(3)
+
-
Smit, E.F.
(3)
+
-
Velden, D.L. van der
(3)
+
-
Werkhoven, E. van
(3)
+
-
Zeverijn, L.J.
(3)
+
-
Aarntzen, E.H.J.G.
(2)
+
-
Adamus, G.
(2)
+
-
Amundson, D.
(2)
+
-
Bel, M.
(2)
+
-
Boon, C.J.F.
(2)
+
-
Boxtel, W. van
(2)
+
-
Buter, J.
(2)
+
-
Dijk, E.H.C. van
(2)
+
-
Erdkamp, F.
(2)
+
-
Fiets, E.
(2)
+
-
Geus-Oei, L.F. de
(2)
+
-
Gort, E.H.
(2)
+
-
Groot, D.J. de
(2)
+
-
Haar, J. van de
(2)
+
-
Hamberg, P.
(2)
+
-
Hendriks, M.P.
(2)
+
-
Jager, M.J.
(2)
+
-
Jansman, F.G.A.
(2)
+
-
Jong, M.A. de
(2)
+
-
Kapiteijn, E.H.W.
(2)
+
-
Kerver, E.D.
(2)
+
-
Keunen, J.E.E.
(2)
+
-
Krens, S.D.
(2)
+
-
Leng, W.J. de
(2)
+
-
Leng, W.W.J. de
(2)
+
-
Lolkema, M.P.
(2)
+
-
Lubberman, F.J.E.
(2)
+
-
Luyten, G.P.M.
(2)
+
-
Marinkovic, M.
(2)
+
-
Meerten, E. van
(2)
+
-
Moes, D.J.A.R.
(2)
+
-
Morreau, H.
(2)
+
-
Vervenne, W.L.
(2)
+
-
Willems, S.M.
(2)
+
-
Willemsen, A.E.C.A.B.
(2)
+
-
Witjes, M.J.H.
(2)
+
-
Show more
Language
en
(29)
+
-
Search results
(1 - 24 of 29)
Pages
1
2
›
››
show grid
show list
save search
Limited clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin D-CDK4/6 pathway alterations in the Dutch DRUP and Australian MoST trials
Patients with rare cancers in the drug rediscovery protocol (DRUP) benefit from genomics-guided treatment
89Zr-DFO-durvalumab PET/CT before durvalumab treatment in patients with recurrent or metastatic head and neck cancer
Economic evaluation of a tumour-agnostic therapy
The gap between rare and common cancers still exists: Results from a population-based study in the Netherlands
Patients with rare cancers in the Drug Rediscovery Protocol (DRUP) benefit from genomics-guided treatment
Exposure-response analyses of cabozantinib in patients with metastatic renal cell cancer
The impact of a 1-hour time interval between pazopanib and subsequent intake of gastric acid suppressants on pazopanib exposure
Prospective practice survey of management of cetuximab-related skin reactions
Methotrexate plus or minus cetuximab as first-line treatment in a recurrent or metastatic (R/M) squamous cell carcinoma population of the head and neck (SCCHN), unfit for cisplatin combination treatment, a phase Ib-randomized phase II study Commence
The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs
The Effect of Using Pazopanib With Food vs. Fasted on Pharmacokinetics, Patient Safety, and Preference (DIET Study)
Ototoxicity in locally advanced head and neck cancer patients treated with induction chemotherapy followed by intermediate or high-dose cisplatin-based chemoradiotherapy
Everolimus Exposure and Early Metabolic Response as Predictors of Treatment Outcomes in Breast Cancer Patients Treated with Everolimus and Exemestane
Cetuximab in combination with methotrexate (MTX) as first-line treatment in recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): A phase Ib randomized phase II study versus single agent MTX
A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The Netherlands
Quality of life of patients with locally advanced head and neck cancer treated with induction chemotherapy followed by cisplatin-containing chemoradiotherapy in the Dutch CONDOR study: a randomized controlled trial
Androgen deprivation therapy for androgen receptor-positive advanced salivary duct carcinoma: A nationwide case series of 35 patients in The Netherlands
Optimizing the dose in cancer patients treated with imatinib, sunitinib and pazopanib
Impact of chemotherapy on the outcome of osteosarcoma of the head and neck in adults
Positron emission tomography response criteria in solid tumours criteria for quantitative analysis of [F-18]-fluorodeoxyglucose positron emission tomography with integrated computed tomography for treatment response assessment in metastasised solid tumour
Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil followed by randomization to two cisplatin-based concomitant chemoradiotherapy schedules in patients with locally advanced head and neck cancer (CONDOR study) (Dutch Head and Neck Society 08-0
Serous Retinopathy Associated with Mitogen-Activated Protein Kinase Kinase Inhibition (Binimetinib) for Metastatic Cutaneous and Uveal Melanoma
Serous retinopathy associated with MEK inhibition (binimetinib) for metastatic cutaneous and uveal melanoma
Pages
1
2
›
››
